Management of cancer patients during COVID-19 pandemic at developing countries

Table 1 Retrospective reports about cancer patients with severe acute respiratory syndrome coronavirus 2 infection

Ref.	n1	Mean age	Outcomes	Results
Liang et al[74], 2020	18	63	Severe clinical events (ICU admission and mechanical ventilation or death)	Severe clinical events: 39% (7/18 patients) vs 8% (126/1572 patients without cancer) (P = 0.0003)
Zhang et al[72], 2020	28	65	Severe clinical events (ICU admission, life-threatening complications or death)	Severe clinical events: 53.6% (15/28 patients). Death rate: 28.6% (8/28 patients)
Dai et al[75], 2020	105	64	Death rate, ICU admission and severe or critical symptom	Death rate: 11.4% (OR 2.34, P = 0.03); ICU admission: 19.0% (OR 2.84, P < 0.01); Severe or critical symptom: 34.3% (OR 2.79, P < 0.01)
Barlesi et al[79], 20202	137	61	ICU admission or death	ICU admission: 11.0% (15/137 patients); Death rate: 14.6% (20/137patients)
Yang et al[76], 2020	205	63	ICU admission or death	ICU admission: 15.0% (30/205 patients); Death rate: 20.0% (40/205 patients)
Kuderer et al[77], 2020	928	66	ICU admission, mechanical ventilation or death	ICU admission: 14.2% (132/928 patients); Mechanical ventilation: 12.5% (116/928 patients); Death rate: 13.0% (121/928patients)
Garassino et al[78], 20203	200	68	ICU admission, mechanical ventilation in hospitalised patient and death in all patients	ICU admission: 8.8% (13/147 patients); Mechanical ventilation: 6.1% (9/147 patients); Death rate: 33.0% (66/200 patients)

¹Patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) confirmed and cancer.

²Results reported at congress, some patient are not discharged at the time of calculate finals outcomes.

³Results from a cohort with thoracic malignancies and SARS-CoV-2 confirmed infection. ICU: Intensive care unit.